Urinary Markers of Detrusor Overactivity in Spina Bifida Patients

NCT02852317 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 134

Last updated 2018-09-11

No results posted yet for this study

Summary

The purpose of this study is to assess diagnostic performance of urinary markers of detrusor overactivity (Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF), adenosine triphosphate (ATP), Prostaglandine E2) in detected high pressure bladder un spina bifida patients.

Conditions

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-16
Primary Completion
2017-03-29
Completion
2017-07-17

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02852317 on ClinicalTrials.gov